Latest Strategy Changes News

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.

Skylark Minerals reports solid progress in its Simon Copper and Perseverance Projects with ongoing fieldwork analysis, while maintaining a strong cash position and advancing gold asset acquisitions.

Australian Foundation Investment Company Limited (AFIC) reported a $285 million net profit for FY2025, declaring a fully franked 14.5c final dividend plus a 5c special dividend tied to capital gains from portfolio adjustments.

Boss Energy Limited reported a $7.7 million operating cash outflow in the June 2025 quarter, reducing its cash reserves to $36.5 million. The company’s cash runway now stands at just under five quarters amid ongoing investment and operational costs.

Noble Helium has upgraded its North Rukwa helium resource estimate by nearly 30%, driven by fresh data and a refined charge model, setting the stage for a targeted drilling campaign.

Boss Energy has exceeded its FY25 production and cost targets at the Honeymoon Uranium Project, marking a major milestone of over 1 million pounds of uranium produced since commissioning. The company’s robust balance sheet and operational ramp-up position it well for growth amid a strengthening uranium market.

DXN Limited reported a robust Q4 FY25 with 51% revenue growth, securing key contracts and completing a strategic property acquisition that strengthens its modular data centre footprint.

D3 Energy has achieved a significant milestone with maiden reserve certification for its South African ER315 permit, alongside a 32% boost in gas flow rates and strategic expansions into Australia and South Africa.

Global Lithium Resources has made significant progress on its Manna Lithium Project, advancing its Definitive Feasibility Study and securing a key variation to its offtake agreement with Canmax. The company also reported a substantial reduction in its cash burn rate, maintaining a strong cash position.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

QMines Limited reports promising high-grade copper and zinc intersections from its maiden drilling at Sulphide City, bolstering confidence in the Develin Creek project’s potential.